That's what keeps me invested and adding more shares: THE RECOVERY RX. It seems obvious that company management interest and attention is now focused on that potentially explosive sales product. Our CEO has quietly implied such. With KT, DONJOY and SAI now actively selling the Actipatch product, the company is free to concentrate on RX and devote most of its time and attention to that product. And I for one, am happy to finally see that product get their full attention, as IMO it could be the dynamite, when lit, that blows the cover off this stock price. That, if successful selling and using in medical and surgical centers, could be the bright light that Big Pharma or major medical device companies will see, take notice and cannot ignore.

AGAIN, how MANY surgeries done everyday, world wide? WOW!